>>> US Gapping up

Gapping up
In reaction to strong earnings/guidance:

PPP +23.7%, WTW +15.1%, FEYE +15%, MYGN +12.4%, BGFV +10.1%, RRD +9.3%, PGH +8.3%, FSLR +8.1%, GNW +6.8%, LNTH +6.2%, HUBS +5.9%,DLPH +5.9%, NVO +5.7%, CG +5.7%, BYD +4.6%, (also reinstates dividend), OCN +4.3%, QUAD +4.2%, (light volume), GDDY +3.6%, MDLZ +3.5%, VSH +3.4%, EL +3.2%, CSOD +3.2%, PKD +3%, CNK +3%, MTOR +3%, PAYC +2.9%, EVHC +2.9%, KLIC +2.8%, TEX +2.8%, ANGI +2.8%,ZAGG +2.6%, FANG +2.2%, QGEN +2.1%, AERI +2.1%, TAHO +2%, (ticking higher), PZZA +1.9%, YUM +1.7%, NEWS +1.5%, RSPP +1.5%, QLYS +1.2%,CGNT +1.1%, ADRO +1%, TWX +1%

M&A news:

LOV +21.2% (Spark Networks unveils merger with Affinitas GmbH, operator of online dating platforms EliteSingles, eDarling and Attractive World)
STRP +19.2% (determines that a revised offer from a multi-national telecommunications company for $135.96/share constitutes a 'superior proposal')
OB +15.4% (Onebeacon Insurance to be acquired by Intact Financial (IFCZF) for $18.10 in cash per share or $1.7 bln )
CTXS +5.3% (fielding interest from several interested acquirers after bids were submitted last week, according to Bloomberg)

Other news:

PIRS +52.5% (Pieris Pharmaceuticals and AstraZeneca (AZN) to collaborate to develop and commercialize Anticalin)
PHMD +32.2% (continued strength; First Capital Real Estate Trust discloses 16.6% active stake pursuant to previously announced contribution agreement )
PSTI +9.9% (announces 'promising' study results for PLX-R18 as a treatment for Acute Radiation Syndrome)
PRTO +8.1% (will increase the planned enrollment of its ongoing Phase 3 PATENCY-2 trial to 600 patients)
BLRX +5.5% (anticipates initiating Phase 3 study of Bl-8040 as a novel stem cell mobilization treatment for autologous bone-marrow transplantation, following 'successful' meeting w/ the FDA, during the 2H17)
VRX +4.7% (continued strength)
VICL +3.3% (provides update on its internal programs VL-2397 for invasive aspergillosis and the HSV-2 therapeutic vaccine at its R&D day; full data set will be presented on June 2 as one of four presentations at the ASM Microbe 2017 conference)
APRI +2% (Intracoastal Capital discloses 5.6% passive stake)
QLYS +1.2% (in sympathy with FEYE)
FTNT +0.9% (in sympathy with FEYE)

Analyst comments: